CN100386061C - Low antigen hetero stroma of cornea treated by frozen, and its prepn. method - Google Patents
Low antigen hetero stroma of cornea treated by frozen, and its prepn. method Download PDFInfo
- Publication number
- CN100386061C CN100386061C CNB2005100503463A CN200510050346A CN100386061C CN 100386061 C CN100386061 C CN 100386061C CN B2005100503463 A CNB2005100503463 A CN B2005100503463A CN 200510050346 A CN200510050346 A CN 200510050346A CN 100386061 C CN100386061 C CN 100386061C
- Authority
- CN
- China
- Prior art keywords
- cornea
- corneal
- eyeball
- stroma
- heterogeneous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
The present invention provides a heterogeneous corneal stroma with a low antigen, which is realized by the following technical scheme: (1) the fresh eyeball of an animal is taken, and is placed at-70DEGC to be frozen and preserved; (2) the heterogeneous eyeball in the state of freezing preservation is radiated by gamma rays, and is preserved at-20 DEG C to 70 DEG C to be prepared for use; (3) when the heterogeneous eyeball is used, the heterogeneous eyeball is unfrozen at normal temperature, a full cornea is cut along a corneal limbus, and the epithelium and the endoderm of the full cornea are torn off to obtain the heterogeneous corneal stroma with a low antigen. Not only can all cells in the heterogeneous corneal stroma which is obtained by the method of the present invention be killed, but also the basic structure of cornea collagen fiber of the cornea can be preserved, and thereby, the toughness and the transparence of the cornea is preserved; meanwhile, the heterogeneous corneal stroma has very low immunogenicity and favorable biocompatibility. The heterogeneous corneal stroma as a medical material can be directly used for operations of treatment corneal transplantation and optical plate layer corneal transplantation. An implanted sheet can survive for a long time, and the purpose of corneal transplantation is completely achieved.
Description
Technical field
The invention belongs to medical material, relate to a kind of corneal stroma, relate in particular to a kind of low antigenic hetero stroma of cornea and preparation method through freezing processing, this hetero stroma of cornea can be used as medical material and is applied to corneal transplantation and cornea refractive surgery.
Background technology
Keratopathy is the second largest disease that causes blinding in the global range.For the patient of keratopathy blinding, have only by corneal transplantation just to make the patient recover vision.In China,, and accept only thousands of examples in patient's every year of corneal transplantation because of annual nearly 250,000 examples of the patient of keratopathy blinding.The basic reason that the restriction corneal transplantation is carried out is the extreme scarcity in donor's cornea source.Therefore, researching and developing out the cornea substitute that can substitute people's cornea is the key that solves this imbalance between supply and demand.
The history of the existing many decades of artificial cornea's research, the research in past mainly concentrates on the materialogy aspect.Because people's cornea is the part of wall of eyeball, not only requiring concerning graft substitute has strict optical characteristics, also must possess simultaneously and the highly organized biocompatibility of human eye.In recent years, the structure that develops into the artificial cornea of tissue engineering technique provides new thinking and method.Minami etc. were the reconstruction in vitro that substrate has realized the artificial cornea in 1993 with the collagen gel, but failed to be used for transplant operation owing to the transparency difference of gel and intensity are low.Griffith in 1999 etc. cultivate genetically modified endothelium and epithelial cell on the substrate based on collagen-chondroitin sulfate, rebuild all similar biological cornea of function, structure to normal cornea, but also fail to enter animal experiment stage, just differ farther from clinical practice because matrix strength is not enough.Therefore, the cornea biomaterial of synthetic is also very undesirable so far.Up to now relevant artificial cornea's biomaterial is studied topmost limitation and is, can't prepare the substrate framework that has the similar transparency, intensity and biological characteristics to people's cornea.
Hetero stroma of cornea such as porcine cornea substrate have and the similar organizational structure of people's corneal stroma, biophysical properties and optical characteristics.But intensive rejection has hindered heterogenic cornea application clinically after the xenotransplantation.Stromal cell in the discovering in recent years, corneal stroma is the major antigen that causes the matrix type rejection.And as collagen fiber high conservative between kind of system of corneal stroma framework, the difference of organizational structure and biophysical properties is little, and antigenicity is very low.
Can make keratocyte death by stored frozen and freeze thawing treatment, make its cell surface can not the expression tissue compatibility antigen etc. participate in the molecule of immunological rejection, thereby the antigenicity of hetero stroma of cornea is significantly reduced, and can kill the pathogenic microorganism that may exist in the heterogenic cornea by radiation gamma.
Therefore, using physical method such as freezing processing to make the stromal cell death of heterogenic cornea, thereby its antigenicity is lowered, may be the desirable substitute of people's corneal stroma.
Summary of the invention
An object of the present invention is to provide a kind of low antigenic hetero stroma of cornea.
Another object of the present invention provides the preparation method of this low antigenic hetero stroma of cornea, is achieved through the following technical solutions:
(1) obtain the fresh animal eyeball: win animal eyeball, prune and to be soaked in after the eyeball surface affiliated group in 5% betagen solution 3 minutes, wash with 500 milliliters of balanced salt solutions then, used animal mainly comprises pig, cattle, Canis familiaris L..Then animal eyeball is placed-70 ℃ of stored frozen.
(2) radiation gamma is handled: the xenogenesis eyeball under the stored frozen state is carried out the radiation gamma that dosage is 25kGy, kill the pathogenic microorganism that may exist.
(3) obtain and preserve: be stored in-20 ℃-70 ℃ standbyly behind the radiation gamma, use often that relaxing the bowels with purgatives of warm nature thaws, operating microscope lower edge limbus of corneae is cut the full-shape film, tears corneal epithelium and corneal endothelial layer off, obtains low antigenic hetero stroma of cornea.
The application that another purpose of the present invention is this hetero stroma of cornea through freezing processing in the medical material of using as preparation corneal transplantation and refractive surgery.
Main feature of the present invention is: both can kill all cells in the corneal stroma through freezing and radiation gamma method of the present invention, and can preserve the basic framework of corneal collagen fiber again, thereby keep the toughness and the transparency of cornea.Hetero stroma of cornea after the processing has very low immunogenicity and excellent biological compatibility.It can be directly used in therapeutic corneal and transplant and optical lamellar cornea transplant operation, the corneal epithelium of transplanting the back receptor makes this hetero stroma of cornea plant the superficial epitheliumization of sheet very soon, the keratocyte of receptor and the nerve hetero stroma of cornea of can growing into is again planted in the sheet, plant sheet and survive for a long time, reach the purpose of corneal transplantation fully.
Description of drawings
Fig. 1 is freezing cornea EthD-1 and 5-CMFDA double fluorescent dyeing photo.
Fig. 2 is for being behind the xenogenesis lamellar keratoplasty of donor 3 days with the stored frozen porcine cornea.
Fig. 3 is for being behind the xenogenesis lamellar keratoplasty of donor 1 year with the stored frozen porcine cornea.
The specific embodiment
Below will the present invention is further illustrated by embodiment.
The preparation of embodiment 1 freezing processing porcine cornea substrate
In qualified feed lot, select the healthy donors pig, with after the penthiobarbital pin intramuscular injection anesthesia, win the Oculus sus domestica ball, prune after the eyeball surface affiliated group and eyeball to be soaked in 5% povidone iodine 3 minutes, with 500 milliliters of phosphoric acid balanced salt solution flushings, be placed on-70 ℃ of stored frozen then.Xenogenesis eyeball under the stored frozen state is carried out the radiation gamma that dosage is 25kGy, kill the pathogenic microorganism that may exist.Then it is stored in-70 ℃ standby.
After thawing under the eyeball room temperature, operating microscope lower edge limbus of corneae is cut the full-shape film, scrapes off corneal epithelium and tears posterior elastic membrane off, obtains low antigenic porcine cornea substrate.This corneal stroma inner cell is all dead, the visible living cells fluorescent dye of fluorescence staining 5-CMFDA non-coloring, and dead cell fluorescent dye EthD-1 makes keratocyte dye redness, referring to Fig. 1.
The preparation of embodiment 2 freezing processing Cornu Bovis seu Bubali membrane matrixs
In qualified feed lot, select the healthy donors cattle, after penthiobarbital pin intramuscular injection anesthesia, win the buphthalmos ball, prune after the eyeball surface affiliated group and eyeball to be soaked in 5% povidone iodine 3 minutes, wash with 500 ml physiological salines then, be transported to laboratory under 4 degrees centigrade, place-70 ℃ of normal saline stored frozen.
Xenogenesis eyeball under the stored frozen state is carried out the radiation gamma that dosage is 25kGy, kill the pathogenic microorganism that may exist.Then it is stored in-20 ℃ standby.During use, after thawing under the eyeball room temperature, operating microscope lower edge limbus of corneae is cut the full-shape film, tears corneal epithelium and posterior elastic membrane off, obtains low antigenic Cornu Bovis seu Bubali membrane matrix.
Embodiment 3 new zealand rabbit therapeutic corneal transplantation experiments
Low antigen Cornu Bovis seu Bubali membrane matrix with the preparation of embodiment 2 methods is medical donor material (to call donor in the following text), selecting healthy new zealand rabbit is receptor bound therapeutic Penetrating Keratoplasty, after rabbit usefulness penthiobarbital intramuscular injection success general anesthesia, the conventional PVP iodine sterilization of art eye, drape, eyelid left by eye speculum, do the inferior retcus anchor suture, donor's cornea with normal saline flushing after in substrate face up and place on the cornea pad, with 7.5 millimeters trepans after recipient cornea central authorities are drilled into the anterior chamber, inject viscoelastic agent in the place ahead, wipe out recipient cornea and prepare plant bed along boring edge with corneal scissors, get and plant sheet and place on the plant bed, with 10-0 nylon wire (Alcon Laboratories, Fort Worth TX) makes 16 pin interrupted sutures.Art finishes removes rectus suture and eye speculum, and (SantanPharmaceutics, Osaka Japan) are coated with eye with the tarivid eye ointment.Postoperative gives once a day, and the tarivid eye ointment is coated with eye.Observe conjunctival congestion, epithelization is finished and situation such as rejection generation.Transplant back discovery conjunctival congestion and disappear after 5 days, the epithelization postoperative was finished in 3 days, and no rejection takes place in 3 months observation period.
The optical lamellar cornea transplantation experiments of embodiment 4 new zealand rabbits
The low antigen porcine cornea substrate for preparing with embodiment 1 method is medical donor material (to call donor in the following text), selecting healthy new zealand rabbit is the receptor bound lamellar keratoplasty, after the penthiobarbital intramuscular injection success general anesthesia, the conventional povidone iodine sterilization of art eye, drape, eyelid left by eye speculum, does the inferior retcus anchor suture, donor's cornea faces up with substrate in normal saline flushing is after 10 minutes and places on the cornea pad, drills through donor with 7.75 millimeters trepans and plants sheet.After recipient cornea central authorities are drilled into about 2/3 cornea degree of depth, separate flaggy with 7.5 millimeters trepans with cornea lamellar blade.Get and plant sheet and place plant bed, (Alcon Laboratories, FortWorth TX) make 16 pin interrupted sutures with the 10-0 nylon wire.Art finishes removes rectus suture and eye speculum, and the tarivid eye ointment is coated with eye.Postoperative gives once a day, and the tarivid eye ointment is coated with eye.Observation conjunctival congestion, epithelization are finished indexs such as situation and the change of angle transparency.Transplant back discovery conjunctival congestion and disappear after 3 days, epithelization was finished in 3 days, and no rejection takes place in 12 months observation period, and corneal transparency is referring to Fig. 2, Fig. 3.
Need not further to elaborate, believe and adopt the disclosed content in front, those skilled in the art can use the present invention to greatest extent.Therefore, the embodiment of front is interpreted as only illustrating, but not limits the scope of the invention by any way.
The partial reference document that the present invention relates to
1.Whitcher?JP，Srinivasan?M，Upadhyay?MP.Corneal?blindness：a?globalperspective.Bull?World?Health?Organ?2001；79(3)：214-21.
2.Hicks?C，Crawford?G，Chirila?T，et?al.Development?and?clinical?assessmentof?an?artificial?cornea.Prog?Retin?Eye?Res?2000；19(2)：149-70.
3.Chirila?TV.An?overview?of?the?development?of?artificial?corneas?withporous?skirts?and?the?use?of?PHEMA?for?such?an?application.Biomaterials2001；22(24)：3311-7.
4.Minami?Y，Sugihara?H，Oono?S.Reconstruction?of?cornea?inthree-dimensional?collagen?gel?matrix?culture.Invest?Ophthalmol?Vis?Sci1993；34(7)：2316-24.
5.Griffith?M，Osborne?R，Munger?R，et?al.Functional?human?cornealequivalents?constructed?from?cell?lines.Science?1999；286(5447)：2169-72.
6.Trinkaus-Randall?V，Nugent?MA.Biological?response?to?a?synthetic?cornea.J?Control?Release?1998；53(1-3)：205-14.
7.Kampmeier?J，Radt?B，Birngruber?R，Brinkmann?R.Thermal?andbiomechanical?parameters?of?porcine?cornea.Cornea?2000；19(3)：355-63.
8.Ross?JR，Howell?DN，Sanfilippo?FP.Characteristics?of?corneal?xenograftrejection?in?a?discordant?species?combination.Invest?Ophthalmol?Vis?Sci1993；34(8)：2469-76.
9.Amano?S，Shimomura?N，Kaji?Y，et?al.Antigenicity?of?porcine?cornea?asxenograft.Curr?Eye?Res?2003；26(6)：313-8.
Claims (3)
1. the low antigenic hetero stroma of cornea through freezing processing is a material with the animal corneal, it is characterized in that: provide a kind of low antigenic hetero stroma of cornea through freezing processing, be achieved through the following technical solutions:
(1) obtains the fresh animal corneal stroma: win animal eyeball, prune and to be soaked in after the eyeball surface affiliated group in 5% povidone iodine 3 minutes, wash with 500 milliliters of balanced salt solutions then, then animal eyeball is placed-70 ℃ of balanced salt solution stored frozen;
(2) radiation gamma is handled: the xenogenesis eyeball under the stored frozen state is carried out the radiation gamma that dosage is 25kGy, kill the pathogenic microorganism that may exist;
(3) obtain and preserve: be stored in-70 ℃ standbyly behind the radiation gamma, use often that relaxing the bowels with purgatives of warm nature thaws, operating microscope lower edge limbus of corneae is cut the full-shape film, tears corneal epithelium and corneal endothelial layer off, obtains low antigenic hetero stroma of cornea.
2. the low antigenic hetero stroma of cornea through freezing processing according to claim 1 is characterized in that: the described balanced salt solution of step (1) is selected phosphoric acid balanced salt solution or normal saline for use.
3. the application of low antigenic hetero stroma of cornea in the medical material that preparation corneal transplantation, cornea refractive surgery are used through freezing processing according to claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100503463A CN100386061C (en) | 2005-05-17 | 2005-05-17 | Low antigen hetero stroma of cornea treated by frozen, and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100503463A CN100386061C (en) | 2005-05-17 | 2005-05-17 | Low antigen hetero stroma of cornea treated by frozen, and its prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1692891A CN1692891A (en) | 2005-11-09 |
| CN100386061C true CN100386061C (en) | 2008-05-07 |
Family
ID=35352137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100503463A Expired - Fee Related CN100386061C (en) | 2005-05-17 | 2005-05-17 | Low antigen hetero stroma of cornea treated by frozen, and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100386061C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101840726B1 (en) * | 2013-10-31 | 2018-03-21 | 유비전 바이오텍 컴퍼니 리미티드 | Method for preparing heterogenous corneal material |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1985778B (en) * | 2005-12-20 | 2010-10-13 | 广东冠昊生物科技股份有限公司 | Artificial biological cornea |
| CN101947144B (en) * | 2010-09-29 | 2012-07-04 | 厦门大学 | Ply tissue engineering corneal frame and manufacturing method and application thereof |
| WO2018107487A1 (en) * | 2016-12-16 | 2018-06-21 | 厦门大开生物科技有限公司 | Method of sterilizing cornea by irradiation and cornea sterilized thereby |
| CN106821546B (en) * | 2017-01-14 | 2019-08-16 | 中山大学中山眼科中心 | The preparation method of the corneal stroma lens of the low antigen handled through roentgen radiation x |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5827641A (en) * | 1992-11-13 | 1998-10-27 | Parenteau; Nancy L. | In vitro cornea equivalent model |
| US5891617A (en) * | 1993-09-15 | 1999-04-06 | Organogenesis Inc. | Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing |
| CN1473551A (en) * | 2003-08-07 | 2004-02-11 | 中山大学中山眼科中心 | Artificial tissue engineeing biological cornea |
| CN1579342A (en) * | 2004-04-28 | 2005-02-16 | 浙江大学医学院附属邵逸夫医院 | Exogenous cornea substrate without cells and its preparation method and use |
-
2005
- 2005-05-17 CN CNB2005100503463A patent/CN100386061C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5827641A (en) * | 1992-11-13 | 1998-10-27 | Parenteau; Nancy L. | In vitro cornea equivalent model |
| US5891617A (en) * | 1993-09-15 | 1999-04-06 | Organogenesis Inc. | Cryopreservation of harvested skin and cultured skin or cornea equivalents by slow freezing |
| CN1473551A (en) * | 2003-08-07 | 2004-02-11 | 中山大学中山眼科中心 | Artificial tissue engineeing biological cornea |
| CN1579342A (en) * | 2004-04-28 | 2005-02-16 | 浙江大学医学院附属邵逸夫医院 | Exogenous cornea substrate without cells and its preparation method and use |
Non-Patent Citations (1)
| Title |
|---|
| 角膜体外重建异种生物载体材料生物相容性研究. 郝念，吴静，李姝燕，徐锦堂，赵松滨.眼科研究，第22卷第2期. 2004 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101840726B1 (en) * | 2013-10-31 | 2018-03-21 | 유비전 바이오텍 컴퍼니 리미티드 | Method for preparing heterogenous corneal material |
| US10072244B2 (en) | 2013-10-31 | 2018-09-11 | Youvision Biotech Co., Ltd. | Method for preparing heterogenetic corneal material |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1692891A (en) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100333702C (en) | Exogenous cornea substrate without cells and its preparation method and use | |
| Zhang et al. | Lamellar keratoplasty treatment of fungal corneal ulcers with acellular porcine corneal stroma | |
| CN101917932B (en) | Method for processing porcine cornea for decellularization | |
| Gospodarowicz et al. | Transplantation of cultured bovine corneal endothelial cells to species with nonregenerative endothelium: the cat as an experimental model | |
| CN101274106B (en) | Method for preparing acellular matrix | |
| CN1243573C (en) | Pre-fabricated corneal tissue lens and method of corneal overlay to correct vision (II) | |
| CN102294053B (en) | Acellular heterogeneous corneal stroma carrier and preparation method and application thereof | |
| CN104189957B (en) | Fresh pig cornea is utilized to prepare method and the application of tissue engineering comea carrier bracket | |
| CN101947144B (en) | Ply tissue engineering corneal frame and manufacturing method and application thereof | |
| CN101985051A (en) | Acellular cornea or acellular corneal stroma, preparation method and application thereof | |
| CN1311072C (en) | Preparation method of dried active amnion | |
| CN100386061C (en) | Low antigen hetero stroma of cornea treated by frozen, and its prepn. method | |
| CN1289259A (en) | Prostheses with associated growth factors | |
| CN101306207B (en) | Tissue engineered cornea epithelial transplantation membrane and preparation method and use thereof | |
| CN101432031A (en) | Conjunctival tissue system | |
| CN104288837B (en) | A kind of acellular dermal matrix and its production and use | |
| CN109550080A (en) | A kind of artificial bilayer's skin and preparation method thereof | |
| CN1326502C (en) | Artificial tissue engineeing biological cornea | |
| CN110354311A (en) | Extracellular matrix composite transparent matter acid gel and preparation method thereof, application and biomaterial | |
| Zhang et al. | In situ growth induction of the corneal stroma cells using uniaxially aligned composite fibrous scaffolds | |
| CN103349794B (en) | Restructuring alpha-galactosidase removes method and the product of xenogeneic skin antigen | |
| CN100484497C (en) | A method for preparing bioactivity possessed artificial cornea | |
| CN105688282A (en) | Novel biological artificial cornea capable of realizing cellularization through in-vivo induction as well as realizing quick transparency | |
| CN102697581A (en) | Method for constructing tissue engineering blood vessel | |
| CN111035807B (en) | Preparation method of ultrathin APCS (amorphous silicon copper-zinc copper) implant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080507 Termination date: 20130517 |